From human monocytes to genome-wide binding sites : a protocol for small amounts of blood: Monocyte Isolation/ChIP-Protocol/Library Amplification/Genome Wide Computational Data Analysis by Weiterer, Sebastian et al.
From Human Monocytes to Genome-Wide Binding Sites -
A Protocol for Small Amounts of Blood: Monocyte
Isolation/ChIP-Protocol/Library Amplification/Genome
Wide Computational Data Analysis
Sebastian Weiterer1,2, Florian Uhle1, Sabin Bhuju3, Michael Jarek3, Markus A. Weigand1,2,
Marek Bartkuhn4*
1Department of Anesthesiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Germany, 2German Centre for Infection Research (DZIF), partner site
Giessen-Marburg-Langen, Giessen, Germany, 3Genome Analytics, Helmholtz Centre for Infection Research, Braunschweig, Germany, 4 Institute for Genetics, Justus-Liebig-
University, Giessen, Germany
Abstract
Chromatin immunoprecipitation in combination with a genome-wide analysis via high-throughput sequencing is the state
of the art method to gain genome-wide representation of histone modification or transcription factor binding profiles.
However, chromatin immunoprecipitation analysis in the context of human experimental samples is limited, especially in
the case of blood cells. The typically extremely low yields of precipitated DNA are usually not compatible with library
amplification for next generation sequencing. We developed a highly reproducible protocol to present a guideline from the
first step of isolating monocytes from a blood sample to analyse the distribution of histone modifications in a genome-wide
manner. Conclusion: The protocol describes the whole work flow from isolating monocytes from human blood samples
followed by a high-sensitivity and small-scale chromatin immunoprecipitation assay with guidance for generating libraries
compatible with next generation sequencing from small amounts of immunoprecipitated DNA.
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Introduction
Epigenetic regulatory mechanisms like covalent histone modi-
fications and DNA methylation mediate changes in gene
expression without changing the underlying DNA sequence. In
the first case histones can be posttranslationally modified on their
N-terminal tails by enzymes with different kinds of modifying
qualities, resulting in acetylated, methylated or phosphorylated
amino acid residues. Previous studies showed that the specific
presence or absence of such histone modifications in defined
genomic, especially cis-regulatory regions like promoters is
correlated with the expression of associated genes. For example
it has been clearly demonstrated, that trimethylation (me3) of
lysine (K)4 and an acetylation (ac) of K9 of histone H3 are
associated with transcriptionally active or at least poised promoter
regions. In contrast a trimethylation of H3K27 can be found at
repressed loci [1],[2],[3],[4].
Hence, an analysis of epigenetic parameters can help under-
standing gene regulatory mechanisms underlying gene expression
programs. In addition, studying these epigenetic parameters in
cells affected by disease may reveal new findings about unknown
pathophysiological mechanisms [5],[6].
ChIP (chromatin immunoprecipitation) is the method of choice
to analyze the occurrence of histone modifications and transcrip-
tion factors in a native chromatin context. Since the arrival of
high-throughput technologies like tiling microarrays (ChIP-chip)
and especially since it is possible to sequence immunoprecipitated
DNA in a massively parallel fashion (ChIP-seq) it is possible to
obtain precise maps of such epigenetic marks on a genome-wide
scale. On the other hand there are still a couple of limitations
under certain experimental settings that hamper an easy and
reproducible workflow [7]. These are majorly dependent on the
requirements for the amounts of ChIP-DNA that have to be used
with the majority of library preparation protocols. This is
especially true in case of biological/medical studies that rely on
the usage of limited primary cell material, like (in our study)
monocytes.
Monocytes are cells of the innate immune system and play a key
role in the human body’s defence mechanism. They are derived
from hematopoietic stem cells in the bone marrow [8]. After
passing through several progenitor stages they terminally differ-
entiate into monocytes, with several scavenger receptors for
pathogen recognition. Under inflammatory conditions stimulation
can induce the release of mediators to activate subsequent immune
response mechanisms [9] [10]. In addition, monocytes have the
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potential to move via the bloodstream to target tissues in order to
differentiate into dendritic cells and macrophages during an
infection [11] [12].
Different kinds of cell surface receptors are known, that can
classify monocyte subpopulations based on their expression levels
(CD14++ CD16-, classical monocytes; CD14+ CD16++ non-
classical monocytes; CD14++ CD16+ intermediate monocytes)
[13]. The classical CD14++ CD16- monocytes seem to play an
important role in different kinds of diseases, like cardiovascular
diseases [14], or relevant immune processes, as the initial pro-
inflammatory cascade of the innate immune system during sepsis
[15]. They also represent a central factor in the impact of immune
dysfunction especially dealing with severe bacterial infections [16].
In addition a persistence of the compensatory anti-inflammatory
response syndrome is associated with monocyte dysfunction [17].
Although there is a correlation between immunological dysfunc-
tion and the monocyte human leukocyte antigen-DR, which can
be used as a marker for immunsuppression, the clear pathophys-
iological structure cannot be determined [18,19],[20]. Despite all
efforts in the immunological field, the exact mechanisms leading to
diseases involving pathological changes in monocyte phenotype
and monocyte dysfunction are still unclear. A genome-wide
epigenetic analysis of CD14++ CD16- monocytes from critically ill
patients with different kinds of inflammatory diseases has a great
potential to reveal novel pathophysiological mechanisms.
This protocol is a guideline for the experimenter from the first
steps of isolating monocytes from a blood sample to the genome-
wide analysis of histone modifications via cross-linked ChIP-seq.
So far such a protocol for limited amounts of primary blood cells,
which would be reproducibly applicable with donors’ or patients’
blood, has not been described in the literature. As a consequence
of the limited availability of human blood samples and due to
inherent loss of cells during cell purification the starting amount of
cells is usually not enough to obtain sufficient amounts of
immunoprecipitated DNA to meet the requirements for standard
library preparation protocols. Therefore we expanded our
protocol and included the steps of a robust library amplification
protocol compatible with such low DNA amounts into the
workflow. Furthermore, we scaled down our protocol to uncrit-
ically small blood sample sizes, which safely can be taken from
critically ill patients.
In conclusion, the following protocol describes the complete
workflow from isolating monocytes from human blood samples to
a high-sensitivity and small-scale chromatin immunoprecipitation
assay. In addition instructions for amplification of sequencing
libraries from small amounts of immunoprecipitated DNA assures
sufficient DNA quantity for performing ChIP-seq and subsequent
genome wide computational data analysis.
Materials and Methods
Experimental Design (see Fig. 1)
Monocyte isolation. A blood sample of 30 ml was taken and
peripheral blood mononuclear cells were isolated using ficoll-based
density gradient centrifugation. Further isolation of CD14++
CD16- monocytes was conducted using magnetic cell sorting to
deplete CD16++ monocytes and separate CD14++ monocytes.
Purity of isolation was checked by flow cytometric analysis of the
CD14+ cell fraction.
Cell preparation. Cells were cross-linked for 10 min using
formaldehyde (final concentration 1%).
ChIP protocol. The ChIP protocol was optimized for small
amounts of monocytes. Chromatin has to be sheared using
ultrasound sonication. To gain satisfying results, a specialised
sonication programme with additional adapted cooling is indis-
pensable. We designed a shortened ChIP protocol, where
immunoprecipitation, reverse cross-linking and DNA purification
is executed within 2 days.
Library amplification. Library amplification was conducted
using a specially modified library preparation kit protocol to
supervise library amplification with the presence of SYBR Green
in a real-time PCR machine.
ChIP sequencing. Sequencing of the libraries was performed
on an Illumina HiSeq 2000.
Computational data analysis. In addition to identification
of enriched and depleted genomic regions and annotations,
correlation analysis was performed to compare and validate data
quality. Furthermore we compared our data to publicly available
expression data in order to identify functional relationships
between chromatin states and gene expression.
Ethics Statement
All research was conducted according to the principles
expressed in the Declaration of Helsinki, and approved by the
ethics committee of the medical faculty of the Justus-Liebig-
University of Giessen (Klinikstrasse 32, D-35385 Giessen,
Germany) with the approval number 155/12. Subjects provided
written, informed consent on forms approved by the Institutional
Review Board.
Reagents
N PBS (1%)
N PBS (1%) +EDTA (2 mM) +BSA (5%)
N CD16 MicroBeads (Miltenyi Biotec)
N CD14 MicroBeads (Miltenyi Biotec)
N FITC anti-human CD14 Antibody (BioLegend)
N Formaldehyde
N Glycine
N Protease inhibitors (Roche complete). Dissolve 1 tablet in
10 ml H2O to obtain 10x concentrated stock solution
N Lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris/HCl,
pH8.1, 1x concentrated protease inhibitors)
N Agarose A/G-Beads (CalBiochem IP-05)
Figure 1. Experimental design/workflow. Diagram shows the
experimental design for a complete workflow to analyse genome wide
histone modifications of CD 14++ CD 16- monocytes using 30 ml of
blood.
doi:10.1371/journal.pone.0094164.g001
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N Dilution buffer (SDS 0.01%, Triton X-100 1%, EDTA
1.2 mM, Tris/HCl, pH 8.1 16.7 mM, NaCl 167 mM)
N Low-salt wash buffer (SDS 0.1%, Triton X-100 1%, EDTA
2 mM, Tris/HCl, pH8.1 20 mM, NaCl 150 mM)
N High-salt wash buffer (SDS 0.1%, Triton X-100 1%, EDTA
2 mM, Tris/HCl, pH8.1 20 mM, NaCl 500 mM)
N LiCL wash buffer (LiCl 0.25 M, NP40 1%, Deoxycholat 1%,
EDTA 1 mM, Tris/HCl, pH 8.1 10 mM)
N TE (Tris/HCl, pH8.1 10 mM, EDTA 1 mM)
N RNase A
N Proteinase K
N SYBR Green I dye (Life Technologies)
N 80% ethanol
N Ficoll
qPCR primer:
TLR4 forward TGTGTGCCCTGGTTTGTTTA.
TLR4 reverse GCCCCTGTTAGCACTCAAAA.
HMGB1 con1 forward AAGCTGTGTACGGTGTGTGC.
HMGB1 con1 reverse GCCTCCTAAAAAGGTCCTTGA.
Equipment
N Illustra GFX PCR DNA and Gel Band Purification kit (GE
Healthcare Life Sience)
N Sonifier 250 (Branson)
N Qubit Fluorometric Quantitiation (Life Technologies)
N Magnetic cell sorting (autoMACS, Miltenyi Biotec)
N Flow cytometer (e.g. FACSCalibur, BD Bioscience)
N MicroPlex Library Preparation kit (Diagenode)
N Real-time PCR (Bio-Rad CFX96)
N AMPure XP beads (Agencourt)
N Magnetic rack
N Hematology analyzer (Sysmex KX-21N)
Sequencing and Computational Methods
Sequencing. 4 barcoded libraries (input, H3K9ac, H3K4me3
and H3K27me3) per donor were prepared and sequenced on a
single lane of an Illumina HiSeq 2000. In total we generated data
sets for 4 donors. Cluster generation was performed using the
Illumina cluster station. Sequencing on the Illumina HiSeq 2000
followed a standard protocol. The fluorescent images were
processed to sequences using the Genome Analyzer Pipeline
Analysis software 1.8 (Illumina). All sequencing data was deposited
at NCBI’s gene expression omnibus (GEO) under the accession
number GSE54634.
Processing of ChIP-seq reads and peak calling. ChIP-seq
reads were converted to fastq format and aligned to a precompiled
hg19 reference index with BOWTIE [21]. Unambiguously
mapped and unique reads were kept for subsequent generation
of binding profiles and calling of peaks using PeakRanger [22] and
MACS [23], where the sequencing reads from input DNA were
used as control. We applied an FDR-threshold of 0.05. All
downstream analyses were done in R/BioConductor (http://
www.bioconductor.org). We made use of the following R/
BioConductor packages: GenomicRanges [24], GenomicFeatures [25]
and chipseq [26].
After extension of reads continuous coverage vectors were
calculated and z-standardized to account for differential library
sizes. Those coverage vectors were used for visualization in
genome browsers as well as to collect data in 5 kb windows
spanning the transcriptional start sites of all RefSeq genes. The
binding data was binned across binding sites in 50 bp bins and the
mean was calculated at each position in order to generate profiles
of binding data. K-means clustering was done using seqMINER
[27].
Identification of enriched/depleted genomic
annotations. Annotations (transcriptional start sites (TSS),
transcriptional end sites (TES), 210kb to 21 kb upstream of
genes (TSS upstream), introns and exons) were derived from
human hg19 RefSeq genes downloaded from UCSC genome
database. H3K4me3 and H3K27me3 peak ranges were intersect-
ed with these intervals and the relative association was calculated
and compared to the genomic background.
Correlation analysis. We determined the number of reads
mapping to the promoters (from21kb upstream to 1 kb down-
stream from the transcriptional start site) of all RefSeq genes. After
quantile normalization we calculated Pearson’s correlation coef-
ficient for all pair wise combinations of experiments.
Public data sets used in this study. In order to obtain gene
expression values for all genes in a highly similar cell type we used
a pre-aligned (hg19) BAM-file from a CD14+ monocyte long-
RNA-seq (ENCODE consortium [28]) downloaded via the UCSC
interface:
wgEncodeCshlLongRnaSeqMonocd14CellPamAlnRep1.bam
Reads were imported into R and for each RefSeq gene we
determined the number of reads within exons. These count data
were normalized by dividing them by the respective gene length.
Finally expression values were log2 transformed.
Procedure
Monocyte Isolation (Day 1)
1. Transfer 30 ml blood into a 50 ml tube.
2. Isolate peripheral blood mononuclear cells via density gradient
centrifugation (Ficoll).
3. Wash the pellet of peripheral blood mononuclear cells (repeat
this step 2 times):
– add room-temperature (RT) PBS (Phosphate-Buffered
Saline) (1%) up to 30 ml.
– centrifuge cells at RT at 1500 rpm for 5 min,
– remove the supernatant and discard.
4. Add room-temperature (RT) PBS (1%) up to 30 ml, centrifuge
cells at RT at 800 rpm for 10 min, remove the supernatant and
discard.
5. Add 2 ml PBS (1%) +EDTA (2mM) +BSA (5%) and resuspend
pellet.
6. Dilute a small amount of the cell suspension 1:10 (e.g.: 10 ml
cell suspension+90 ml PBS) to determine cell number using a
hematology analyser (Sysmex) for subsequent antibody calcu-
lation.
7. Centrifuge cells at RT at 800 rpm for 10 min, remove and
discard the supernatant.
Critical step!. Pure isolation of peripheral blood mononu-
clear cells at this point is one of the key steps that can affect a
successful outcome. On the other hand the recurrent wash steps
can cause significant loss of cells.
Caution!. The use of blood samples from patients, who had
multiple blood transfusions or blood dialysis may lead to
impureness of the peripheral blood mononuclear cells gained
with the density gradient centrifugation. In addition, also an
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increased immune reaction may affect purity of the density
gradient centrifugation.
CD16 Depletion
8. Add 50 ml PBS (1%) +EDTA (2mM) +BSA (5%)/56107 cells+
50 ml CD16 MicroBeads (Miltenyi Biotec)/56107 cells.
9. Mix well and incubate for 30 minutes at 4uC.
10. Wash cells with 2 ml per 107 cells and centrifuge 10 min
with 300 g at 4uC. Resuspend with 500 ml PBS (1%) +
EDTA (2 mM) +BSA (5%)/108 cells.
11. Proceed with depletion using magnetic cell sorting or
manual cell sorting.
12. Dilute a small part of the cell suspension 1:10 (e.g.: 10 ml cell
suspension+90 ml PBS (1%)) to determine cell number.
Critical step!. Inexact incubation time may cause unspecific
binding and loss of CD14++ CD 16- monocytes.
CD14 Separation
13. Add 80 ml PBS (1%) +EDTA (2 mM) +BSA (5%)/107 cells+
20 ml CD14 MicroBeads (Miltenyl Biotec)/107 cells.
14. Mix well and incubate for 15 minutes at 2–8uC.
15. Wash cells with 1–2 ml/107 cells and centrifuge 10 min
with 300 g at 4uC. Resuspend with 500 ml PBS (1%) +
EDTA (2 mM) +BSA (5%)/108cells.
16. Proceed with separation using automatic magnetic cell
sorting or manual magnetic cell sorting.
17. Dilute a small part of the cell suspension 1:10 (e.g.: 10 ml cell
suspension+90 ml PBS (1%)) to determine cell number using
hematology analyser.
Critical step!. Disregard of incubation time may cause
unspecific binding and loss of purity.
FACS (Fluorescence-Activated Cell Sorting) Analysis
18. Centrifuge isolated CD14++ CD16- monocytes with 300 g
for 10 minutes. Resuspend in 2 ml PBS (1%) at RT.
19. Extract 100 ml cell suspension, add 20 ml antibodies (FITC
anti-human CD14 Antibody, BioLegend) and incubate for
30 minutes in the dark at 2–8uC for FACS analysis.
Caution!. FACS analysis at this point is obligate to assure
pure results and isolation efficiency.
ChIP (Chromatin Immunoprecipitation)
20. Cross-link DNA/protein. Resuspend cells in 2 ml PBS,
add 55.6 ml 37% formaldehyde to adjust to a concentration
of 1% formaldehyde. Incubate at 18uC for precisely 10 min
with gentle shaking.
21. Add 0.125 M final concentration of glycine to stop fixation
(136 ml of 2 M glycine in total of 2 ml cross-linking solution)
and incubate for 5 min at RT.
22. Centrifuge 5 minutes at 2000 rpm at 4uC, remove the
supernatant and discard.
23. Resuspend pellet with 1 ml 4uC PBS (1%). Centrifuge
5 minutes at 2000 rpm at 4uC, remove the supernatant and
discard. Cross-linked cells can be stored at 220uc at this
point. 1. Potential break time on day 1.
Sonication/Shearing Chromatin
24. Add 200 ml lysis buffer to 106 cells in a 1.5 ml tube.
25. Start the sonication with a Branson sonifier to achieve
chromatin fragments of 150–600 base pairs. Secure tube
using a clamp to ensure a constant tip position in the tube
and that the probe does not touch the tube wall. To generate
a constant cooling effect, keep the tube on wet ice with
ethanol during sonication. Use a duty cycle of 10% and
45 sec ‘‘on’’ pulses and 15 sec ‘‘off’’ pulses. Repeat 20 times
resulting in a sonication time of 20 minutes in total.
Critical step!. Sonication is one of the most critical steps in
this protocol. We highly recommend strict adherence. Our
experience using other equipment for sonication did not show
reliable results.
Caution!. We recommend constant cooling during sonication
and strict observance of the ‘‘off’’ pulse time. Skipping the pause
time after 45 sec of sonication may not lead to satisfactory results.
26. After sonication, centrifuge tubes for 10 minutes with
14000 rpm at 4uC. From here on: keep samples on ice/at
4uC.
27. Transfer supernatant into fresh tube. You may freeze your
sample here!
2. Potential Break Time on Day 1.
Caution For use of multiple samples we recommend
sequential processing for the sonication step.
Preparation of Immunoprecipiation
28. Add 1800 ml dilution buffer to the tube with 200 ml of
sheared chromatin (Dilution 1:10).
29. Store 38 ml of the dilution buffer chromatin mix in a
separate tube at 4uC as an ‘‘input’’ extract (10%).
30. Per sample, add 20 ml agarose A/G-beads (Calbiochem) to
2 fresh tubes (one for binding of antibody, one for pre-
clearing of chromatin extract). Add 1 ml dilution buffer, mix
and centrifuge for 1 minute with 5000 rpm at RT and
discard the supernatant.
31. Antibody binding: Add 500 ml dilution buffer and add
appropriate amount of antibody (we used 3 ml) to one of the
agarose A/G-beads filled tubes. Incubate at 4uC in a rotator
for at least 1 hour, centrifuge for 1 minute with 5000 rpm
and discard the supernatant.
32. To pre-clear chromatin add 380 ml of the dilution buffer
chromatin mix in the second of the agarose A/G-beads
filled tubes. Incubate at 4uC in a rotator for at least 1 hour.
33. Centrifuge for 30 sec with 5000 rpm at 4uC.
Immunoprecipitation
34. Transfer pre-cleared chromatin (supernatant) into tubes with
antibody-bound agarose A/G-beads (from step 31).
35. Incubate at 4uC in a rotator for at least 3 hours.
36. Centrifuge for 1 minute with 5000 rpm at 4uC and discard
the supernatant.
Wash Chromatin Bead Complex
37. Add 1 ml of low-salt wash buffer on top of the beads; mix on
a rotator for 10 minutes at 4uC and centrifuge at 5000 rpm.
Remove supernatant and discard.
38. Add 1 ml of high-salt wash buffer on top of the beads; mix
on a rotator for 10 minutes at 4uC and centrifuge at
5000 rpm. Remove supernatant and discard.
From Human Monocytes to Genome-Wide Binding Sites
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!.
39. Add 1 ml of LiCL wash buffer on top of the beads; mix on a
rotator for 10 minutes at 4uC and centrifuge at 5000 rpm.
Remove supernatant and discard.
40. Add 1 ml of TE wash buffer on top of the beads; mix on a
rotator for 10 minutes at 4uC and centrifuge at 5000 rpm.
Remove supernatant and discard. Repeat this step one time
and resuspend chromatin bead complex in 100 ml TE at
RT.
41. Add 62 ml of TE wash buffer to the input sample from step
29 to adjust to the same volume as in the immunoprecipated
tubes.
Reverse Cross-linking
42. Add 2 ml RNase A (10 mg/ml) to each tube and incubate for
30 minutes at 37uC (optional: mix on a rotator).
43. Add 5 ml 10% SDS and 2,5 ml Proteinase K (20 mg/ml) and
incubate for 4 h at 37uC. Shift to 65uC over night!.
DNA Purification (Day 2). Use Illustra GFX PCR DNA and
Gel Band Purification kit (GE Healthcare Life Science) and the
‘‘protocol for purification of DNA from solution or an enzymatic
reaction’’ to purify ChIP-DNA, according to manufacturers
recommendations.
44. Add 50 ml of pure H2O for DNA elution. You may freeze
your sample here. 1. Potential break time on day 2.
Determination of Library DNA Amount. For ChIP-DNA
quantitation we recommend to use the Qubit Assay.
qPCR for Validation.
Critical step To ensure that the ChIP was successful, 
(exemplarily shown in Fig. S3).
Library Amplification. To conduct library amplification,
use the MicroPlex Library Preparation kit (Diagenode). After steps
A. ‘‘MicroPlex Template Preparation’’ and B. ‘‘MicroPlex Library
Synthesis’’, which can be done as described, a variation of the
protocol is necessary.
45. After mixing the library amplification buffer, enzyme and
water with the library and 2 ml of Indexing Reagent, extract
27 ml of the solution and add SYBR Green I dye (Life
Technologies) at a 6x final concentration, and process
parallel to the actual tube.
46. Centrifuge the solution and transfer it to a real-time PCR
machine (we used a BioRad CFX96 machine). PCR protocol
as follows:
Step 1: 1 cycle: 72uC 3 min
Step 2: 1 cycle: 85uC 2 min
Step 3: 1 cycle: 98uC 2 min
Step 4: 4 cycles: 98uC 20 sec; 67uC 20 sec, 72uC 20 sec
Step 5: 4–21 cycles 98uC 20 sec, 72uC 50 sec
Remove the non-SYBR Green tubes, when SYBR
Green tubes show a decreasing acceleration in the exponential
curve.
When working with multiple samples avoid
long breaks in the PCR process while removing none-SYBR
Green tubes.
Library Purification. Library purification is adapted to
existing conditions based on the instruction manual for the
MicroPlex Library kit. For library purification use AMPure XP
beads.
Figure 2. Genome browser snap shot of an 80 kb region on chromosome 12 of hg19. Depicted are the z-standardized ChIP-seq coverage
profiles for 2 histone modifications (H3K27me3 and H3K4me3) from 4 blood donors (P1–P4). Strong H3K4me3 binding can be detected around the
transcriptional start sites of the ING4, ZNF384 and COPS7A genes. These genes are majorly devoid of H3K27me3 signals. In contrast the PIANP gene is
strongly enriched for H3K27me3 but shows only weak signals for H3K4me3.
doi:10.1371/journal.pone.0094164.g002
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we advice the execution of qPCR on selected target sequences
!.
Critical step!.
Caution!.
47. Transfer PCR product without SYBR Green to a low
binding tube and add 50 ml of AMPure XP beads.
Resuspend AMPure XP by pipette until no pellet is visible.
48. Incubate 5 minutes at RT, then place tube on magnetic rack
and wait for 2 minutes until beads are bound completely.
We recommend gentle shaking during incu-
bation.
49. Remove tube and proceed further according to manufac-
turers’ recommendations.
50. For final DNA elution add 30 ml of pure H2O.
51. Place tube on magnetic rack and wait for 2 minutes until
beads are bound completely.
52. Remove the supernatant without disturbing the pellet and
transfer to a fresh low binding tube.
qPCR for Validation.
To validate the amplified product, we advice
the execution of qPCR on selected target sequences.
Determination of Library DNA Amount. For determina-
tion use Qubit Assay to quantify amplified DNA products.
Results
In order to show applicability of the approach described above
we purified CD14++ CD16- monocytes and subsequently
prepared formaldehyde-cross-linked chromatin extracts from 4
healthy blood donors. Purity was monitored by FACS and was in
all cases equal or above 95 percent (Fig. S1). For each sample we
performed chromatin-immunoprecipitation experiments with an-
tibodies specific for the histone modifications H3K4me3,
H3K27me3 and H3K9ac. Whereas H3K4me3 [29] and
H3K9ac [30] have been repeatedly shown to be associated with
promoters of actively transcribed genes, H3K27me3 is known for
its role in polycomb-mediated gene repression [31]. After
preparation of barcoded libraries we always sequenced 4 of them
on a single lane of an Illumina HiSeq 2000. After read alignment,
filtering and quality control inspection of the ChIP-seq data
revealed highly similar profiles when comparing the binding data
for a given histone modification across the 4 different donors. This
is exemplarily shown for H3K4me3 and H3K27me3 data in
genome browser snap shots (Fig. 2). Even on this level the high
degree of reproducibility becomes instantly visible. Additionally
several principal features of the data can be appreciated. Of the
four genes in the depicted genomic interval on chromosome 12,
three are strongly marked by H3K4me3 with the typical bimodal
pattern across the transcriptional start sites of the respective genes
(ING4, ZNF384 and COPS7A). These genes are virtually free of
H3K27me3. In contrast the PIANP gene shows only relatively
weak association with H3K4me3 but instead is marked by a strong
H3K27me3 signal. Similar to H3K4me3, the H3K27me3 signal
peaks in the promoter region but is obviously much more spread
out which is in line with reports from the literature [4].
In order to substantiate the observed similarity between
experiments we compared the data for a given antibody on
genome-wide scale. Pair wise scatter-plots comparing the promot-
er association of a given histone mark validate the findings from
inspection of profiles in the genome browsers (Fig. 3A). For
example we found a mean correlation coefficient R2= 0.97 for
H3K4me3 (R2H3K27me3 = 0.85; R
2
H3K9ac = 0.82; Fig. S2). Addi-
tionally, we compared all conducted experiments amongst each
other with respect to their similarity. When we did hierarchical
clustering of the pair wise correlation coefficients we found the
data to segregate into the expected groups. I.e. H3K4me3 and
Figure 3. Correlation analysis shows high reproducibility
between independent biological samples. A) H3K4me3 binding
data from 4 donors was compared against each other with respect to
binding to promoters. Quantile-normalized read counts per promoter
interval (+/21 kb around the transcriptional start sites) were plotted for
all pair-wise combinations as smoothed scatterplots (color-coding of
density is shown in color key). Furthermore Pearson’s R was calculated
for each combination. B) Pair wise correlation was done for H3K4me3,
H3K27me3 as well as H3K9ac data from 4 donors. The hierarchical
cluster analysis of the resulting correlation matrix identifies two major
groups: H3K9ac and H3K4me3 are strongly correlated whereas both are
negatively correlated with H3K27me3 (color-coding of correlation
coefficients is shown in color key).
doi:10.1371/journal.pone.0094164.g003
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Critical step!.
Critical step!.
Figure 4. Histone modifications at promoters of CD 14++ CD 16- monocytes. A) H3K4me3 and H3K27me3 are both enriched at promoters.
Significantly bound regions were compared with the distribution of genomic features (TSS, TSS upstream, TES, exon, intron, intergenic) based on
RefSeq gene annotations. In comparison to the genomic background (genome) both H3K27me3, but especially H3K4me3 are strongly enriched for
TSSs. B) K-means clustering reveals 3 major chromatin states at 44109 RefSeq transcriptional start sites. The heat map shows binding (in red) centered
across a 10 kb interval spanning all RefSeq TSSs for H3K27me3 and H3K4me3 in 4 blood donors. The data was clustered by k-means which separates
the data into 3 major promoter classes: no histone modification (dark blue), high H3K4me3/no H3K27me3 (blue) and low but detectable H3K4me3
and high H3K4me3 (light blue). C) Promoter classes are associated with specific transcriptional output. Gene expression levels in CD14+ monocytes
were calculated for all RefSeq genes (based on ENCODE RNA-seq data, shown as reads per 1 kb of transcript length). Gene expression values of genes
falling into above mentioned categories are plotted as boxplots.
doi:10.1371/journal.pone.0094164.g004
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H3K9ac show a high degree of correlation whereas the repressive
H3K27me3 mark is clearly different from the two active marks
(Fig. 3B).
Optical inspection of the genome browser and the obvious
association with promoter regions prompted us to investigate the
genomic features associated with regions of significant binding in
an unbiased manner. Therefore we compared binding peaks for
H3K4me3 and H3K27me3 with the following genomic annota-
tions: transcriptional start sites (TSS and TSS upstream region),
transcriptional end sites (TES), exons, introns and intergenic
regions. When comparing with the genomic background distribu-
tion of these features it became evident that both H3K4me3 as
well as H3K27me3 are strongly enriched at transcriptional start
sites (Fig. 4A - dark blue bar), although this association is
somewhat stronger for H3K4me3. In order to obtain a systematic
overview about the binding across all annotated promoters within
the human genome, we used the binding profiles for H3K4me3
and H3K27me3 in a 10 kb window around the transcriptional
start sites of all RefSeq (Reference Sequence) promoters and
performed cluster analysis by k-means. The heat-map represen-
tation clearly indicates 3 major classes of promoters (Fig. 4B), those
completely devoid of any modification, those high in H3K4me3
and virtually free of H3K27me3 and those with high levels of
H3K27me3 and low but detectable H3K4me3. We reasoned that
these ‘‘promoter chromatin states’’ might be associated with
distinct transcriptional output. Therefore we extracted expression
values for all RefSeq transcripts from a recent RNA-seq data set
from the ENCODE (Encyclopedia of DNA Elements [32])
consortium obtained from CD14+ monocytes (Fig. 4C). As
expected we find the modification free promoters to be expressed
at very low levels whereas the genes with strong H3K4me3
binding across the TSS (transcription start site) have significantly
higher expression. In contrast bivalently modified promoters are
associated with gene expression levels comparable to those of
unmodified promoters very similar to what has been described for
this specific promoter class [33].
All together these data clearly demonstrate that the method
described above is able to generate highly reproducible, high
quality genome-wide binding data for a specific cell type isolated
from low amounts of blood samples.
Conclusions.
Epigenetic regulation of chromatin displays an
important cellular mechanism to control nuclear processes like
transcription, replication or DNA repair. Misregulation may be
associated with diseases, like tumor growth or cellular dysfunction
[34]. In order to understand the underlying mechanisms and the
consequences of malfunction it is crucial to study this regulatory
system in primary cells derived from human samples. Studying
epigenetic mechanisms largely involves the application of methods
allowing to determine the chromatin landscape on genome-wide
scale, including ChIP-seq. Due to the inherently low amounts of
DNA precipitated with ChIP and the limitations with respect to
available biological sample material we here suggest a protocol
that allows to study chromatin modifications (or binding of
chromatin factors) on genome-wide scale in monocytes purified
from human blood samples. Importantly, sample volume is low
enough in order to be compatible with blood withdrawal from
critically ill patients, an important fact with respect to studying the
impact of disease conditions on epigenetic gene regulation. Key to
the suggested protocol was finding a way to overcome restrictions
regarding the expected amount of precipitated DNA relevant for
the preparation of sequencing libraries. This was achieved by
applying a commercially available solution that allows preparation
of libraries from very low amounts of starting material.
Collectively, the method generates highly reproducible binding
profiles and therefore allows studying epigenetic mechanisms in
low amounts of chromatin derived from human monocytes. The
particular cell type has proven to be potentially relevant for disease
related processes affecting the human immune response. Never-
theless, the methods should be applicable to other sub-populations
of human blood cells, too.
Supporting Information
Figure S1 Purity of isolated monocytes as determined
by FACS. FACS experiment with anti-human CD14 antibody
shows the efficiency of the isolation after CD16 - PBMC depletion
and following CD14++ monocyte separation. To determine the
purity of the cell isolation by flow cytometry, initial conservative
gating on all cellular events was performed based on forward-/side
scatter properties and subsequent determination of CD14+ cellular
events within this gate.
(TIF)
Figure S2 Correlation analysis for H3K27me3 and
H3K9ac. A) H3K27me3 binding data from 4 donors was
compared against each other with respect to binding to promoters.
Quantile-normalized read counts per promoter interval (+/21 kb
around the transcriptional start sites) were plotted for all pair-wise
combinations as smoothed scatterplots (color-coding of density is
shown in color key). Furthermore Pearson’s R was calculated for
each combination. B) Same as in A) for H3K9ac.
(PDF)
Figure S3 qPCR for validation of individual ChIP.
Exemplary ChIP-qPCR for one of the analysed donors: analysis
of H3K4me3 and H3K27me3 binding to the promoter of the
TLR4 gene and a control region of the HMGB1 locus is shown.
The TLR4 gene is active in CD14++ CD16- monocytes and
accordingly we find strong association of H3K4me3 with the
promoter. In contrast no H3K27me3 can be detected. As expected
the control region in the HMGB1 locus (HMGB1 con1) is devoid
of both histone modifications.
(TIF)
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